Immune function and biodefense in children, elderly and immunocompromised populations
Ended Definitive Contract Awarded Last action
- Contract number
- HHSN266200500030C
- Awardee
-
The Wistar Institute Of Anatomy And Biology UEI DW1XZMGNFBL4
- Awarding agency
-
NIAID DEA OA Acquisitions
National Institutes of Health, Department of Health and Human Services
- Obligated
- $10,764,775
Award facts
- Contract value 47% obligated
-
- $18,921,197.00 Current, with exercised options
- $23,012,476.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- Not on record
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 21 offers Basic Research
- Pricing
- Cost No Fee
- Place of performance
- Philadelphia, PA 19104, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Additional Work (new agreement, FAR part 6 applies) | $0 | |
| Funding Only Action | $679,595 | |
| Funding Only Action | $1,928,758 | |
| Funding Only Action | $2,162,521 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $1,044,746 | |
| Funding Only Action | $1,044,746 | |
| Funding Only Action | $2,166,406 | |
| Original award | $1,738,003 |
About this award
This federal contract award, valued at $23,012,476.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) to The Wistar Institute of Anatomy and Biology, a non-profit biomedical research organization located in Philadelphia, Pennsylvania. The contract, which does not have a set-aside designation, is for research focused on immune function and biodefense in children, elderly, and immunocompromised populations. As a subcontractor, The Wistar Institute has previously provided research services related to the development of universal and enhanced influenza vaccines, including creating DNA-encoded vaccine candidates, testing combination vaccine cocktails, and refining a nucleic acid vaccine delivery platform. The Wistar Institute has also been awarded a $40.5 million indefinite delivery/indefinite quantity (IDIQ) contract from the Defense Advanced Research Projects Agency (DARPA) to develop synthetic DNA-encoded monoclonal antibodies targeting COVID-19 and future pandemic threats.
Quick answers
Who was awarded contract HHSN266200500030C?
HHSN266200500030C was awarded to The Wistar Institute Of Anatomy And Biology by NIAID DEA OA Acquisitions (National Institutes of Health) on August 25, 2005.
How much is contract HHSN266200500030C worth?
The government has obligated $10,764,775 on HHSN266200500030C. Its current value, with exercised options, is $18,921,197. Its potential value, with all options, is $23,012,476.
Was contract HHSN266200500030C competed?
The extent of competition for HHSN266200500030C was full and open competition. The government received 21 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award